91 related articles for article (PubMed ID: 1826545)
1. The effect of aminoguanidine on the blood-retinal barrier in streptozocin-induced diabetic rats.
Cho HK; Kozu H; Peyman GA; Parry GJ; Khoobehi B
Ophthalmic Surg; 1991 Jan; 22(1):44-7. PubMed ID: 1826545
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
Kusari J; Zhou SX; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1044-51. PubMed ID: 19710406
[TBL] [Abstract][Full Text] [Related]
3. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
[TBL] [Abstract][Full Text] [Related]
4. Calcein fluorophotometry in streptozocin-induced diabetic rats.
Golshani MR; Khoobehi B; Peyman GA; Aras C
Ophthalmic Surg; 1994 Aug; 25(8):526-31. PubMed ID: 7970535
[TBL] [Abstract][Full Text] [Related]
5. Breakdown of the inner and outer blood retinal barrier in streptozotocin-induced diabetes.
Do carmo A; Ramos P; Reis A; Proença R; Cunha-vaz JG
Exp Eye Res; 1998 Nov; 67(5):569-75. PubMed ID: 9878219
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral administration of Stephania tetrandra S. Moore on neovascularization of retinal and choroidal capillaries of diabetes in rats.
Tsutsumi T; Hagino N; Liang XC; Guo SS; Kobayashi S
Phytother Res; 2008 May; 22(5):591-6. PubMed ID: 18444245
[TBL] [Abstract][Full Text] [Related]
7. Effect of piroxicam on the blood-retina barrier in experimentally induced diabetes in rats.
Bahgat M; Anis HH; Peyman GA; Farahat HG; Parry GJ; Khoobehi B
Int Ophthalmol; 1991 Sep; 15(5):335-41. PubMed ID: 1835966
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.
Tamura H; Miyamoto K; Kiryu J; Miyahara S; Katsuta H; Hirose F; Musashi K; Yoshimura N
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1440-4. PubMed ID: 15790913
[TBL] [Abstract][Full Text] [Related]
9. Effect of cyclosporin-A on the blood--retinal barrier permeability in streptozotocin-induced diabetes.
Carmo A; Cunha-Vaz JG; Carvalho AP; Lopes MC
Mediators Inflamm; 2000; 9(5):243-8. PubMed ID: 11200365
[TBL] [Abstract][Full Text] [Related]
10. [The relations between doses of streptozotocin and pathosis in induced diabetes mellitus].
Nishigaki A; Noma H; Kakizawa T
Shikwa Gakuho; 1989 Mar; 89(3):639-62. PubMed ID: 2533996
[TBL] [Abstract][Full Text] [Related]
11. Influence of metabolic control on the blood-retinal barrier in streptozocin diabetic rats.
Kernell A; Dahlkvist H; Arnqvist H; Ludvigsson J
Graefes Arch Clin Exp Ophthalmol; 1985; 222(4-5):179-81. PubMed ID: 15835015
[TBL] [Abstract][Full Text] [Related]
12. Aminoguanidine--effects on endoneurial vasoactive nitric oxide and on motor nerve conduction velocity in control and streptozotocin-diabetic rats.
Dewhurst M; Omawari N; Tomlinson DR
Br J Pharmacol; 1997 Feb; 120(4):593-8. PubMed ID: 9051296
[TBL] [Abstract][Full Text] [Related]
13. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
[TBL] [Abstract][Full Text] [Related]
14. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
[TBL] [Abstract][Full Text] [Related]
15. Effect of pyridoxine on the blood-retina barrier in experimentally induced hyperglycemia in rats.
Anis HH; Bahgat M; Peyman GA; Farahat HG; Parry GJ; Khoobehi B
Can J Ophthalmol; 1991 Dec; 26(7):354-7. PubMed ID: 1837242
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
[TBL] [Abstract][Full Text] [Related]
17. Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats.
Agardh E; Hultberg B; Agardh C
Curr Eye Res; 2000 Jul; 21(1):543-9. PubMed ID: 11035534
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of melatonin and aminoguanidine on the cornea in streptozotocin-induced diabetic rats.
Gül M; Emre S; Eşrefoğlu M; Vard N
Cornea; 2008 Aug; 27(7):795-801. PubMed ID: 18650666
[TBL] [Abstract][Full Text] [Related]
19. Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vector.
Shyong MP; Lee FL; Kuo PC; Wu AC; Cheng HC; Chen SL; Tung TH; Tsao YP
Mol Vis; 2007 Jan; 13():133-41. PubMed ID: 17293777
[TBL] [Abstract][Full Text] [Related]
20. Potential prophylactic role of aminoguanidine in diabetic retinopathy and nephropathy in experimental animals.
El Shazly AH; Mahmoud AM; Darwish NS
Acta Pharm; 2009 Mar; 59(1):67-73. PubMed ID: 19304559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
